Skip to content
Disclosery

AlphaCentric Advisors LLC: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of AlphaCentric Advisors LLC on GMED, newest first. How the timeline and the estimate are built.

AlphaCentric Advisors LLC held 10,000 GMED shares at 2026-06-30 per its 13F-HR filed 2026-07-24.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 10,000 shares
    Change vs previous 13F +2,500 shares

    0.67% of the 13F portfolio, value $790,100.

    13F-HR 0001580642-26-004575 filed by AlphaCentric Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 7,500 shares
    Change vs previous 13F -1,212 shares

    0.65% of the 13F portfolio, value $646,200.

    13F-HR 0001580642-26-003040 filed by AlphaCentric Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 8,712 shares
    Change vs previous 13F -15,464 shares

    0.76% of the 13F portfolio, value $760,645.

    13F-HR 0001580642-26-001010 filed by AlphaCentric Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 24,176 shares
    Change vs previous 13F not available

    2% of the 13F portfolio, value $1,999,597.

    13F-HR 0001162044-25-000112 filed by AlphaCentric Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).